Literature DB >> 36036353

Uremic encephalopathy: A definite diagnosis by magnetic resonance imaging?

Farzad Sina1, Darya Najafi2, Alireza Aziz-Ahari3, Elham Shahraki4, Tahere Zarouk Ahimahalle5, Zeinab Namjoo6, Sajad Hassanzadeh7.   

Abstract

The aim of this study was to investigate the magnetic resonance imaging (MRI) findings for the diagnose uremic encephalopathy and describe the usefulness of MRI findings in the ultimate diagnosis of uremic encephalopathy (UE). A total of 20 patients with uremic encephalopathy admitted to the hospital were evaluated in this prospective study. The clinical manifestations, laboratory and MRI imaging findings, demographic information, and clinical outcome were analyzed for each patient. We observed that the 20 prospectively reviewed patients with UE had no involvement of the basal ganglia or the lentiform fork sign (LFS). However, two-thirds of the patients had white matter involvement, and 80% of the subjects had cerebral or cortical atrophy. The arterial blood gas (ABG) analysis revealed that 50% of the patients suffered from metabolic acidosis (n=10). The results of the present study demonstrated that although the observation of Lentiform Fork Sign and Basal Ganglia involvement in MRI of UE patients is a specific finding the absence of which does not rule out UE. Thus, simultaneous examination of clinical manifestation and laboratory test analyses, along with imaging findings, should also be taken into account.

Entities:  

Year:  2022        PMID: 36036353      PMCID: PMC9580542          DOI: 10.4081/ejtm.2022.10613

Source DB:  PubMed          Journal:  Eur J Transl Myol        ISSN: 2037-7452


  38 in total

1.  Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy?

Authors:  S O Casey; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

Review 2.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

3.  Reversible cytotoxic brain edema and facial weakness in uremic encephalopathy.

Authors:  Harald Prüss; Eberhard Siebert; Florian Masuhr
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

4.  Posterior reversible encephalopathy syndrome: a truly treatable neurologic illness.

Authors:  Esther V Hobson; Ian Craven; S Catrin Blank
Journal:  Perit Dial Int       Date:  2012 Nov-Dec       Impact factor: 1.756

5.  Lentiform fork sign: Uremia alone or multifactorial causation?

Authors:  Ajay Jaryal; Suresh Thakur; Joginder Singh Pathania; Sanjay Vikrant; Dinesh Kumar; Lokesh Verma
Journal:  Hemodial Int       Date:  2019-12-16       Impact factor: 1.812

6.  Cyclosporine-related reversible posterior leukoencephalopathy: MRI.

Authors:  J M Jarosz; D C Howlett; T C Cox; J B Bingham
Journal:  Neuroradiology       Date:  1997-10       Impact factor: 2.804

7.  Acute movement disorders with bilateral basal ganglia lesions in uremia.

Authors:  H C Wang; P Brown; A J Lees
Journal:  Mov Disord       Date:  1998-11       Impact factor: 10.338

8.  Evidence that disruption of the blood-brain barrier precedes reduction in cerebral blood flow in hypertensive encephalopathy.

Authors:  K Tamaki; S Sadoshima; G L Baumbach; C Iadecola; D J Reis; D D Heistad
Journal:  Hypertension       Date:  1984 Mar-Apr       Impact factor: 10.190

9.  Acute bilateral basal ganglia lesions in diabetic uraemia: diffusion-weighted MRI.

Authors:  Eun Ja Lee; Jong-Ho Park; Yon kwon Ihn; Young Joo Kim; Seon Kyu Lee; Chan Sup Park
Journal:  Neuroradiology       Date:  2007-10-06       Impact factor: 2.804

10.  Uremic Encephalopathy: MR Imaging Findings and Clinical Correlation.

Authors:  D M Kim; I H Lee; C J Song
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-28       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.